Chemopreventive activity of very low dose dietary tannic acid administration in hepatoma bearing C3H male mice

Cancer Letters

Volumn 141, Issue 1-2, 1999, Pages 57-62

  Nepka, Charitini ^a   Sivridis, Efthimios ^b   Antonoglou, Orpheus ^c   Kortsaris, Alexander ^c   Georgellis, Antonis ^d   Taitzoglou, Ioannis ^f   Hytiroglou, Prodromos ^e   Papadimitriou, Constantine ^e   Zintzaras, Ilias ^f   Kouretas, Demetrios ^f  

^a Cytopathology Laboratory   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

^c THEAGENIO CANCER HOSPITAL   (Greece)

^d Res Ctr for Environmental Illness   (Sweden)

^e ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^f UNIVERSITY OF THESSALY   (Greece)

Author keywords

Chemoprevention; Hepatocarcinogenesis; Mice; Tannic acid; Tannins

Indexed keywords

TANNIN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADENOMA; ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOMA, HEPATOCELLULAR; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENETIC PREDISPOSITION TO DISEASE; HYDROLYZABLE TANNINS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED C3H; TIME FACTORS;

ANIMALIA;

EID: 0033019446     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00145-7     Document Type: Article

References (30)

1. Nepka C., Asprodini E., Kouretas D. Tannins, xenobiotic metabolism and cancer chemoprevention in experimental animals. Eur. J. Drug Metabol. Pharmac. 1999;. in press.
2. Drinkwater N., Hanigan M., Kemp C. Genetic and epigenetic promotion of murine hepatocarcinogenesis. In: Mouse Liver Carcinogenesis, Mechanisms and Species Comparisons. 1990;Alan R. Liss Inc. pp. 163-176.
3. Drinkwater N. Effect of genetic susceptibility on tumor induction. Arkos J. Chemical Induction of Cancer. 1995;Birkhanser, Boston, MA. pp. 451-472.
4. Samuelson G. Drugs of Natural Origin. 1992;Swedish Pharmaceutical Press. pp. 121-125.
5. Machieux J.J., Fleuriet A., Billot J. Fruit Phenolics. 1990;CRC Press, Boca Raton, FL.
6. Sakagami H., Kuribayashi N., Iida M., Sakagami T., Takeda M., Fukuchi K., Gomi K., Ohata H., Momose K., Kawazoe Y. Induction of DNA fragmentation by tannin and lignin related substances. Anticancer Res. 15:(5B):1995;2121-2128.
7. Kashiwada Y., Nonaka G., Nishioka I., Lee J., Bori I., Fukushima Y., Bastow K.F., Lee K.H. Tannins as potent inhibitors of DNA topoisomerase II in vitro. J. Pharm. Sci. 82:1993;487-492.
8. Kouretas D., Papageorgiou A., Antonoglou O. Increased protective activity against acid precipitation of poly-U in the serum of tumor bearing mice. Anticancer Res. 8:1988;1307-1312.
9. Ward J.M. Morphology of hepatocellular neoplasms in B6C3F1 mice. Cancer Lett. 9:1980;319-325.
10. Frith J., Ward J.M. A morphologic classification of proliferative and neoplastic hepatic lesions in mice. J. Environ. Pathol. Toxicol. 3:1979;329-351.
11. Kolaja K.L., Stevenson D.E., Walborg E.F. Jr., Klauning J.E. Reversibility of promoter induced hepatic focal lesion growth in mice. Carcinogenesis. 17:1996;1403-1409.
12. Pitot H.C. Altered hepatic foci: their role in murine hepatocarcinogenesis. Annu. Rev. Pharmacol. Toxicol. 30:1990;465-500.
13. Teebor G.W., Becker F.F. Regression and persistence of hyperplastic hepatic nodules induced by N-2-Fluoroacetamide and their relationship to hepatocarcinogenesis. Cancer Res. 31:1971;1-9.
14. Kolaja K.L., Stevenson D.E., Warborg E.F. Jr., Klaunig J.E. Dose-dependent effects of phenobarbital promotion on preneoplastic hepatic lesions in Fisher 344 rats and B6C3F1 mice: effect on DNA synthesis and apoptosis. Carcinogenesis. 17:1996;947-954.
15. Kolaja K.L., Stevenson D.E., Walborg E.F. Jr., Klaunig J.E. Selective dieldrin promotion of hepatic focal lesions in mice. Carcinogenesis. 17:1996;1243-1250.
16. Yang C., Lee M.J., Chen L., Yang G. Polyphenols as inhibitors of carcinogenesis. Environ. Health Perspect. 105 (Suppl.4):1997;971-976.
17. Barch D., Rundhaugen L., Stoner G., Sokalingum Pillay N., Rosche W. Structure-function relationships of the dietary anticarcinogen ellagic acid. Carcinogenesis. 17:1996;265-269.
18. Hirose M., Ozaki K., Takaba K., Fukushima S., Shirai T., Ito N. Modifying effects of the naturally occurring antioxidants gamma-oryzanol, phytic acid, tannic acid and n-tritriacontane-16,18-dione in a rat wide-spectrum organ carcinogenesis model. Carcinogenesis. 12:1991;1917-1921.
19. Onodera H., Kitaura K., Mitsumori K., Yoshida J., Yasuhara K., Shimo T., Takahashi M., Hayashi Y. Study on the carcinogenicity of tannic acid in F344 rats. Food Chem. Toxicol. 32:1994;1101-1106.
20. Chen G., Perchellet E.M., Gao X.M., Newell S.W., Hemingway R.W., Bottari V., Perchellet J.P. Ability of m-chloroloperoxybenzoic acid to induce the ornithine decarboxylase marker of skin tumor promotion and inhibition of this response by gallotannins, oligomeric proanthocyanidins and their monomeric units in mouse epidermis in vivo. Anticancer Res. 15:1995;1183-1189.
21. Ramanathan R., Tan C.H., Das N.P. Cytotoxic effect of plant polyphenols and fat soluble vitamins on malignant human cultured cells. Cancer Lett. 62:1992;217-224.
22. Prevost M.C., Soulat J.M., Comminges C., Maury F., Aslane R., Cohen-Jonathan E., Cariven C., Lauque D., Chap H. Distinct signal transduction pathways for activation of rabbit alveolar macrophages in vitro by cotton bract tannin. Toxicol. Appl. Pharmacol. 138:1996;65-71.
23. Yang G.Y., Liao J., Kim K., Yurkow E.J., Yang C.S. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis. 19:1998;611-616.
24. Ahmad N., Feyes D.K., Nieminen A.L., Agarwal R., Mukhtar H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J. Natl. Cancer Inst. 89:1997;1881-1886.
25. Dong Z., Ma W., Huang C., Yang C.S. Inhibition of tumor promoter induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res. 57:1997;4414-4419.
26. Vrettou E., Karkavelas G., Christoforidou V., Mediskou S., Papadimitriou C. Immunohistochemical phenotyping and PCNA detection in gastrointestinal stromal tumors. Anticancer Res. 15:1995;943-950.
27. Lee G.-H., Benett L.M., Carabeo R.A., Drinkwater N.R. Identification of hepatocarcinogen resistance genes in DBA/2 mice. Genetics. 139:1995;387-395.
28. Nishida H., Omori M., Fucutomi Y., Ninomiya M., Nishiwaki S., Suganuma M., Moriwaki H., Muto Y. Inhibitory effects of (-)-epigallocatechin gallate on spontaneous hepatoma in C3H/HeNCrj mice and human hepatoma-derived PLC/PRF/5 cells. Jpn. J. Cancer Res. 85:1994;221-225.
29. McCullagh P., Nelder J.A. Generalized Linear Models. 2nd edition :1989;Chapman and Hall, London.
30. Bushman J.L. Green tea and cancer in humans: a review of the literature. Nutr. Cancer. 31:1998;151-159.